The STING agonist, DMXAA, reduces tumor vessels and enhances mesothelioma tumor antigen presentation yet blunts cytotoxic T cell function in a murine model
2022 · Frontiers in Immunology · 19 citations
https://doi.org/10.3389/fimmu.2022.969678
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
918
Citations
7
h-index
7
i10-index
Peter T. Graham is an academic researcher from Royal College of Pathologists of Australasia. The author has contributed to research in topics: Blood Coagulation and Thrombosis Mechanisms & Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses. The author has an h-index of 7, co-authored 10 publications.
ORCID: 0000-0003-3562-5230https://doi.org/10.3389/fimmu.2022.969678
https://doi.org/10.1016/j.pathol.2026.01.289
Click to start Chat